Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections

Susceptibility to tuberculosis is historically ascribed to an inadequate immune response that fails to control infecting mycobacteria. In zebrafish, we find that susceptibility to Mycobacterium marinum can result from either inadequate or excessive acute inflammation. Modulation of the leukotriene A...

Full description

Saved in:
Bibliographic Details
Published inCell Vol. 148; no. 3; pp. 434 - 446
Main Authors Tobin, David M., Roca, Francisco J., Oh, Sungwhan F., McFarland, Ross, Vickery, Thad W., Ray, John P., Ko, Dennis C., Zou, Yuxia, Bang, Nguyen D., Chau, Tran T.H., Vary, Jay C., Hawn, Thomas R., Dunstan, Sarah J., Farrar, Jeremy J., Thwaites, Guy E., King, Mary-Claire, Serhan, Charles N., Ramakrishnan, Lalita
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 03.02.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Susceptibility to tuberculosis is historically ascribed to an inadequate immune response that fails to control infecting mycobacteria. In zebrafish, we find that susceptibility to Mycobacterium marinum can result from either inadequate or excessive acute inflammation. Modulation of the leukotriene A4 hydrolase (LTA4H) locus, which controls the balance of pro- and anti-inflammatory eicosanoids, reveals two distinct molecular routes to mycobacterial susceptibility converging on dysregulated TNF levels: inadequate inflammation caused by excess lipoxins and hyperinflammation driven by excess leukotriene B4. We identify therapies that specifically target each of these extremes. In humans, we identify a single nucleotide polymorphism in the LTA4H promoter that regulates its transcriptional activity. In tuberculous meningitis, the polymorphism is associated with inflammatory cell recruitment, patient survival and response to adjunctive anti-inflammatory therapy. Together, our findings suggest that host-directed therapies tailored to patient LTA4H genotypes may counter detrimental effects of either extreme of inflammation. [Display omitted] ► Conserved eicosanoids are regulated by LTA4H activity and impact inflammatory state ► Genotype-directed modulation of TNF improves outcomes in a zebrafish tuberculosis model ► Drug therapies tailored to lta4h genotype improve infection outcome in zebrafish ► In humans, LTA4H genotype associates with responsiveness to therapy for TB meningitis A polymorphism in a locus that controls the balance between pro- and anti-inflammatory mediators is predictive of response to anti-inflammatory therapy in tuberculous meningitis.
AbstractList Susceptibility to tuberculosis is historically ascribed to an inadequate immune response that fails to control infecting mycobacteria. In zebrafish, we find that susceptibility to Mycobacterium marinum can result from either inadequate or excessive acute inflammation. Modulation of the leukotriene A4 hydrolase (LTA4H) locus, which controls the balance of pro- and anti-inflammatory eicosanoids, reveals two distinct molecular routes to mycobacterial susceptibility converging on dysregulated TNF levels: inadequate inflammation caused by excess lipoxins and hyperinflammation driven by excess leukotriene B4. We identify therapies that specifically target each of these extremes. In humans, we identify a single nucleotide polymorphism in the LTA4H promoter that regulates its transcriptional activity. In tuberculous meningitis, the polymorphism is associated with inflammatory cell recruitment, patient survival and response to adjunctive anti-inflammatory therapy. Together, our findings suggest that host-directed therapies tailored to patient LTA4H genotypes may counter detrimental effects of either extreme of inflammation.
Susceptibility to tuberculosis is historically ascribed to an inadequate immune response that fails to control infecting mycobacteria. In zebrafish, we find that susceptibility to Mycobacterium marinum can result from either inadequate or excessive acute inflammation. Modulation of the leukotriene A₄ hydrolase (LTA4H) locus, which controls the balance of pro- and anti-inflammatory eicosanoids, reveals two distinct molecular routes to mycobacterial susceptibility converging on dysregulated TNF levels: inadequate inflammation caused by excess lipoxins and hyperinflammation driven by excess leukotriene B₄. We identify therapies that specifically target each of these extremes. In humans, we identify a single nucleotide polymorphism in the LTA4H promoter that regulates its transcriptional activity. In tuberculous meningitis, the polymorphism is associated with inflammatory cell recruitment, patient survival and response to adjunctive anti-inflammatory therapy. Together, our findings suggest that host-directed therapies tailored to patient LTA4H genotypes may counter detrimental effects of either extreme of inflammation.
Susceptibility to tuberculosis is historically ascribed to an inadequate immune response that fails to control infecting mycobacteria. In zebrafish, we find that susceptibility to Mycobacterium marinum can result from either inadequate or excessive acute inflammation. Modulation of the leukotriene A4 hydrolase (LTA4H) locus, which controls the balance of pro- and anti-inflammatory eicosanoids, reveals two distinct molecular routes to mycobacterial susceptibility converging on dysregulated TNF levels: inadequate inflammation caused by excess lipoxins and hyperinflammation driven by excess leukotriene B4. We identify therapies that specifically target each of these extremes. In humans, we identify a single nucleotide polymorphism in the LTA4H promoter that regulates its transcriptional activity. In tuberculous meningitis, the polymorphism is associated with inflammatory cell recruitment, patient survival and response to adjunctive anti-inflammatory therapy. Together, our findings suggest that host-directed therapies tailored to patient LTA4H genotypes may counter detrimental effects of either extreme of inflammation. [Display omitted] ► Conserved eicosanoids are regulated by LTA4H activity and impact inflammatory state ► Genotype-directed modulation of TNF improves outcomes in a zebrafish tuberculosis model ► Drug therapies tailored to lta4h genotype improve infection outcome in zebrafish ► In humans, LTA4H genotype associates with responsiveness to therapy for TB meningitis A polymorphism in a locus that controls the balance between pro- and anti-inflammatory mediators is predictive of response to anti-inflammatory therapy in tuberculous meningitis.
Susceptibility to tuberculosis is historically ascribed to an inadequate immune response that fails to control infecting mycobacteria. In zebrafish, we find that susceptibility to Mycobacterium marinum can result from either inadequate or excessive acute inflammation. Modulation of the leukotriene A(4) hydrolase (LTA4H) locus, which controls the balance of pro- and anti-inflammatory eicosanoids, reveals two distinct molecular routes to mycobacterial susceptibility converging on dysregulated TNF levels: inadequate inflammation caused by excess lipoxins and hyperinflammation driven by excess leukotriene B(4). We identify therapies that specifically target each of these extremes. In humans, we identify a single nucleotide polymorphism in the LTA4H promoter that regulates its transcriptional activity. In tuberculous meningitis, the polymorphism is associated with inflammatory cell recruitment, patient survival and response to adjunctive anti-inflammatory therapy. Together, our findings suggest that host-directed therapies tailored to patient LTA4H genotypes may counter detrimental effects of either extreme of inflammation.
Susceptibility to tuberculosis is historically ascribed to an inadequate immune response that fails to control infecting mycobacteria. In zebrafish, we find that susceptibility to Mycobacterium marinum can result from either inadequate or excessive acute inflammation. Modulation of the leukotriene A 4 hydrolase ( LTA4H ) locus, which controls the balance of pro- and anti-inflammatory eicosanoids, reveals two distinct molecular routes to mycobacterial susceptibility converging on dysregulated TNF levels: inadequate inflammation caused by excess lipoxins and hyperinflammation driven by excess leukotriene B 4 . We identify therapies that specifically target each of these extremes. In humans, we identify a single nucleotide polymorphism in the LTA4H promoter that regulates its transcriptional activity. In tuberculous meningitis, the polymorphism is associated with inflammatory cell recruitment, patient survival and response to adjunctive anti-inflammatory therapy. Together, our findings suggest that host-directed therapies tailored to patient LTA4H genotypes may counter detrimental effects of either extreme of inflammation.
Author Ko, Dennis C.
Vickery, Thad W.
McFarland, Ross
Ray, John P.
Roca, Francisco J.
Serhan, Charles N.
Thwaites, Guy E.
Oh, Sungwhan F.
Farrar, Jeremy J.
King, Mary-Claire
Tobin, David M.
Zou, Yuxia
Chau, Tran T.H.
Dunstan, Sarah J.
Vary, Jay C.
Ramakrishnan, Lalita
Hawn, Thomas R.
Bang, Nguyen D.
AuthorAffiliation 5 Hospital for Tropical Diseases, 190 Ben Ham Tu, Quan 5, Ho Chi Minh City, Vietnam
7 Oxford University Clinical Research Unit, Hospital for Tropical Diseases, 190 Ben Ham Tu, Quan 5, Ho Chi Minh City, Vietnam
2 Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710
4 Pham Ngoc Thach Hospital for Tuberculosis and Lung Disease, Ho Chi Minh City, Vietnam
3 Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115
6 Department of Medicine, University of Washington, Seattle, WA 98195
10 Department of Genome Sciences, University of Washington, Seattle, WA 98195
11 Department of Immunology, University of Washington, Seattle, WA 98195
9 Kings College London, Centre for Clinical Infection and Diagnostics Research, St. Thomas’ Hospital, London SE1 9RT, UK
1 Department of Microbiology, University of Washington, Sea
AuthorAffiliation_xml – name: 9 Kings College London, Centre for Clinical Infection and Diagnostics Research, St. Thomas’ Hospital, London SE1 9RT, UK
– name: 2 Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710
– name: 5 Hospital for Tropical Diseases, 190 Ben Ham Tu, Quan 5, Ho Chi Minh City, Vietnam
– name: 7 Oxford University Clinical Research Unit, Hospital for Tropical Diseases, 190 Ben Ham Tu, Quan 5, Ho Chi Minh City, Vietnam
– name: 11 Department of Immunology, University of Washington, Seattle, WA 98195
– name: 1 Department of Microbiology, University of Washington, Seattle, WA 98195
– name: 3 Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115
– name: 8 Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, Oxford University, Oxford OX3 7LJ, UK
– name: 10 Department of Genome Sciences, University of Washington, Seattle, WA 98195
– name: 6 Department of Medicine, University of Washington, Seattle, WA 98195
– name: 4 Pham Ngoc Thach Hospital for Tuberculosis and Lung Disease, Ho Chi Minh City, Vietnam
Author_xml – sequence: 1
  givenname: David M.
  surname: Tobin
  fullname: Tobin, David M.
  organization: Department of Microbiology, University of Washington, Seattle, WA 98195, USA
– sequence: 2
  givenname: Francisco J.
  surname: Roca
  fullname: Roca, Francisco J.
  organization: Department of Microbiology, University of Washington, Seattle, WA 98195, USA
– sequence: 3
  givenname: Sungwhan F.
  surname: Oh
  fullname: Oh, Sungwhan F.
  organization: Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
– sequence: 4
  givenname: Ross
  surname: McFarland
  fullname: McFarland, Ross
  organization: Department of Microbiology, University of Washington, Seattle, WA 98195, USA
– sequence: 5
  givenname: Thad W.
  surname: Vickery
  fullname: Vickery, Thad W.
  organization: Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
– sequence: 6
  givenname: John P.
  surname: Ray
  fullname: Ray, John P.
  organization: Department of Microbiology, University of Washington, Seattle, WA 98195, USA
– sequence: 7
  givenname: Dennis C.
  surname: Ko
  fullname: Ko, Dennis C.
  organization: Department of Microbiology, University of Washington, Seattle, WA 98195, USA
– sequence: 8
  givenname: Yuxia
  surname: Zou
  fullname: Zou, Yuxia
  organization: Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA
– sequence: 9
  givenname: Nguyen D.
  surname: Bang
  fullname: Bang, Nguyen D.
  organization: Pham Ngoc Thach Hospital for Tuberculosis and Lung Disease, Ho Chi Minh City, Vietnam
– sequence: 10
  givenname: Tran T.H.
  surname: Chau
  fullname: Chau, Tran T.H.
  organization: Hospital for Tropical Diseases, 190 Ben Ham Tu, Quan 5, Ho Chi Minh City, Vietnam
– sequence: 11
  givenname: Jay C.
  surname: Vary
  fullname: Vary, Jay C.
  organization: Department of Medicine, University of Washington, Seattle, WA 98195, USA
– sequence: 12
  givenname: Thomas R.
  surname: Hawn
  fullname: Hawn, Thomas R.
  organization: Department of Medicine, University of Washington, Seattle, WA 98195, USA
– sequence: 13
  givenname: Sarah J.
  surname: Dunstan
  fullname: Dunstan, Sarah J.
  organization: Oxford University Clinical Research Unit, Hospital for Tropical Diseases, 190 Ben Ham Tu, Quan 5, Ho Chi Minh City, Vietnam
– sequence: 14
  givenname: Jeremy J.
  surname: Farrar
  fullname: Farrar, Jeremy J.
  organization: Oxford University Clinical Research Unit, Hospital for Tropical Diseases, 190 Ben Ham Tu, Quan 5, Ho Chi Minh City, Vietnam
– sequence: 15
  givenname: Guy E.
  surname: Thwaites
  fullname: Thwaites, Guy E.
  organization: Kings College London, Centre for Clinical Infection and Diagnostics Research, St. Thomas' Hospital, London SE1 9RT, UK
– sequence: 16
  givenname: Mary-Claire
  surname: King
  fullname: King, Mary-Claire
  organization: Department of Medicine, University of Washington, Seattle, WA 98195, USA
– sequence: 17
  givenname: Charles N.
  surname: Serhan
  fullname: Serhan, Charles N.
  organization: Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
– sequence: 18
  givenname: Lalita
  surname: Ramakrishnan
  fullname: Ramakrishnan, Lalita
  email: lalitar@uw.edu
  organization: Department of Microbiology, University of Washington, Seattle, WA 98195, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22304914$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtv1DAUhS1URKeFP8ACsmOV4FcSR0JIaEQfUlElOqwtx77peJTYwfZUGn59HU2pYAOru7jfObr3nDN04rwDhN4SXBFMmo-7SsM4VhQTUhFaYcpeoBXBXVty0tITtMK4o6VoWn6KzmLcYYxFXdev0CmlDPOO8BXSVz6m4hKcT4cZyrsZtB2sLjZbCGq2EIu1csXtnOxkf0GRtlBcu2FU06SSD4fiO8TZu5g3vvh20L5XOkGwalww0Mnm5Wv0clBjhDdP8xxtLr5u1lflze3l9frLTanrtkkl6wdFGSWCYi5a0xDBTI071lOD2QCEcDJoyoEOuFOiF9p0HIMZjOlqbjg7R5-PtvO-n8BocCmoUc7BTiocpFdW_r1xdivv_YNknLGW4mzw4ckg-J97iElONi4RKwd-H2XXCNK0ohP_J2kug2TTTNIjqYOPMcDwfA_BcmlR7uQilEuLklCZhVn07s9PniW_a8vA-yMwKC_VfbBR_rjLDk2uOCdGll8-HQnIgT9YCDJqC06DsSHXIo23_7rgEX9Gurs
CitedBy_id crossref_primary_10_1016_j_tim_2014_01_005
crossref_primary_10_1038_ni_3048
crossref_primary_10_1016_j_cell_2022_08_018
crossref_primary_10_1016_j_micpath_2021_104959
crossref_primary_10_3389_fcimb_2020_00263
crossref_primary_10_1186_s12883_024_03532_3
crossref_primary_10_19185_matters_201604000011
crossref_primary_10_1128_microbiolspec_GPP3_0022_2018
crossref_primary_10_1038_s41467_020_19412_6
crossref_primary_10_1371_journal_pone_0067828
crossref_primary_10_1146_annurev_immunol_093019_125148
crossref_primary_10_1007_s11940_018_0490_9
crossref_primary_10_1164_rccm_201712_2368ED
crossref_primary_10_3389_fimmu_2020_602589
crossref_primary_10_3390_ijms21124489
crossref_primary_10_1007_s00281_015_0522_4
crossref_primary_10_1073_pnas_1301128110
crossref_primary_10_1186_1471_2334_13_460
crossref_primary_10_1007_s11910_017_0796_0
crossref_primary_10_1097_WCO_0b013e3283602814
crossref_primary_10_1016_j_bmcl_2015_11_020
crossref_primary_10_1159_000512531
crossref_primary_10_3390_microorganisms11122944
crossref_primary_10_1038_s41598_023_30923_2
crossref_primary_10_1136_practneurol_2017_001653
crossref_primary_10_2217_fmb_12_86
crossref_primary_10_1007_s11033_014_3741_1
crossref_primary_10_1093_infdis_jiaa672
crossref_primary_10_1093_bmb_ldv003
crossref_primary_10_1371_journal_pone_0166333
crossref_primary_10_1016_j_cyto_2022_156076
crossref_primary_10_1016_j_cell_2013_05_052
crossref_primary_10_1128_MMBR_00024_12
crossref_primary_10_1038_s41577_018_0025_3
crossref_primary_10_1590_0004_282X20130158
crossref_primary_10_1016_j_tube_2016_07_009
crossref_primary_10_1186_s12974_015_0345_1
crossref_primary_10_1242_bio_058559
crossref_primary_10_1371_journal_pone_0063357
crossref_primary_10_1016_j_immuni_2022_04_004
crossref_primary_10_3389_fimmu_2019_00528
crossref_primary_10_1111_imr_12951
crossref_primary_10_3389_fcimb_2019_00116
crossref_primary_10_1093_femspd_ftaa015
crossref_primary_10_1038_nature13489
crossref_primary_10_1371_journal_pone_0163298
crossref_primary_10_1016_j_parint_2013_01_002
crossref_primary_10_1016_j_cell_2013_04_019
crossref_primary_10_1016_j_bbadis_2019_165574
crossref_primary_10_1038_cr_2015_123
crossref_primary_10_1073_pnas_2217673120
crossref_primary_10_1002_cbf_3071
crossref_primary_10_1016_j_tube_2013_09_004
crossref_primary_10_31393_reports_vnmedical_2023_27_2__28
crossref_primary_10_1016_j_pharmthera_2019_107428
crossref_primary_10_1016_j_coi_2013_05_005
crossref_primary_10_2174_1568026621999201211200447
crossref_primary_10_1016_j_tube_2021_102125
crossref_primary_10_1016_j_dci_2019_02_011
crossref_primary_10_4269_ajtmh_18_0947
crossref_primary_10_1155_2017_2432904
crossref_primary_10_18632_oncotarget_9052
crossref_primary_10_1016_j_chom_2014_01_008
crossref_primary_10_3389_fcimb_2019_00335
crossref_primary_10_3389_fmed_2017_00171
crossref_primary_10_1371_journal_pone_0203678
crossref_primary_10_1242_dmm_015453
crossref_primary_10_1016_j_tim_2012_06_002
crossref_primary_10_1242_dmm_015594
crossref_primary_10_3389_fendo_2021_641888
crossref_primary_10_3892_mmr_2016_4840
crossref_primary_10_3389_fimmu_2017_01836
crossref_primary_10_1016_S1473_3099_18_30053_7
crossref_primary_10_1016_j_ijid_2018_02_021
crossref_primary_10_1172_JCI83379
crossref_primary_10_1038_nrd4001
crossref_primary_10_1016_j_tube_2015_04_003
crossref_primary_10_3389_fimmu_2022_919802
crossref_primary_10_1016_j_dci_2015_09_001
crossref_primary_10_1002_jcb_26509
crossref_primary_10_1016_j_tet_2020_131740
crossref_primary_10_5411_wji_v5_i1_16
crossref_primary_10_1073_pnas_1320118110
crossref_primary_10_1039_C5CC07721D
crossref_primary_10_1038_s41421_021_00301_1
crossref_primary_10_1007_s00428_021_03043_3
crossref_primary_10_1155_2013_985743
crossref_primary_10_3389_fimmu_2021_639965
crossref_primary_10_1038_nm0417_398
crossref_primary_10_1111_prd_12034
crossref_primary_10_1111_cmi_12236
crossref_primary_10_1016_j_addr_2016_04_024
crossref_primary_10_1128_IAI_00095_21
crossref_primary_10_14785_lpsn_2014_0014
crossref_primary_10_1183_20734735_0079_2021
crossref_primary_10_1007_s40142_017_0124_7
crossref_primary_10_3389_fimmu_2016_00196
crossref_primary_10_1096_fj_201701308
crossref_primary_10_1007_s00011_017_1081_z
crossref_primary_10_3389_fphar_2017_00689
crossref_primary_10_3389_fimmu_2018_00134
crossref_primary_10_1183_20734735_0149_2021
crossref_primary_10_1007_s00281_015_0538_9
crossref_primary_10_1038_mi_2017_68
crossref_primary_10_1016_j_celrep_2012_06_008
crossref_primary_10_2147_IDR_S380166
crossref_primary_10_1155_2019_9537050
crossref_primary_10_1038_srep22041
crossref_primary_10_1016_j_cmi_2023_07_013
crossref_primary_10_1182_blood_2012_04_423525
crossref_primary_10_3389_fmicb_2018_02603
crossref_primary_10_1111_joim_12780
crossref_primary_10_1164_rccm_201208_1385OC
crossref_primary_10_1073_pnas_2306553120
crossref_primary_10_1016_j_immuni_2016_01_019
crossref_primary_10_1111_myc_13361
crossref_primary_10_1128_microbiolspec_MCHD_0001_2014
crossref_primary_10_1038_ncomms12077
crossref_primary_10_1371_journal_pone_0118789
crossref_primary_10_1016_j_tube_2014_08_014
crossref_primary_10_1093_infdis_jiw156
crossref_primary_10_1007_s40610_020_00137_w
crossref_primary_10_1016_j_celrep_2020_108547
crossref_primary_10_1016_S2213_2600_14_70033_5
crossref_primary_10_1093_femspd_ftw068
crossref_primary_10_1038_s41418_017_0031_1
crossref_primary_10_1371_journal_ppat_1006467
crossref_primary_10_4049_jimmunol_1600266
crossref_primary_10_1016_j_heliyon_2024_e32643
crossref_primary_10_1016_j_medmal_2017_01_006
crossref_primary_10_1242_dmm_015545
crossref_primary_10_1016_j_smim_2014_09_010
crossref_primary_10_1177_0049475515609244
crossref_primary_10_7554_eLife_61722
crossref_primary_10_1038_nri_2017_69
crossref_primary_10_1038_s41540_017_0005_4
crossref_primary_10_7554_eLife_22028
crossref_primary_10_12688_wellcomeopenres_16474_2
crossref_primary_10_12688_wellcomeopenres_16474_1
crossref_primary_10_1371_journal_pone_0060838
crossref_primary_10_1002_14651858_CD002244_pub4
crossref_primary_10_3390_microorganisms10122473
crossref_primary_10_1016_j_cbi_2023_110817
crossref_primary_10_3390_ijms20122868
crossref_primary_10_1128_IAI_00906_19
crossref_primary_10_3389_fimmu_2022_1009016
crossref_primary_10_1016_j_phrs_2020_104857
crossref_primary_10_1038_s42003_019_0442_2
crossref_primary_10_1016_j_jtbi_2013_03_008
crossref_primary_10_1111_imr_12267
crossref_primary_10_4049_jimmunol_1500434
crossref_primary_10_1016_j_tube_2021_102085
crossref_primary_10_1371_journal_ppat_1006687
crossref_primary_10_1016_j_coi_2023_102365
crossref_primary_10_3389_fimmu_2021_659943
crossref_primary_10_1016_j_tips_2015_05_005
crossref_primary_10_3389_fphar_2022_936295
crossref_primary_10_1016_j_chom_2015_06_008
crossref_primary_10_1111_imr_12259
crossref_primary_10_1093_ofid_ofaa475
crossref_primary_10_1183_16000617_0377_2020
crossref_primary_10_1111_imr_12255
crossref_primary_10_1371_journal_ppat_1005469
crossref_primary_10_1016_S1473_3099_18_30055_0
crossref_primary_10_1164_rccm_201311_2106PP
crossref_primary_10_1111_imr_12252
crossref_primary_10_1080_1040841X_2024_2370979
crossref_primary_10_3389_fmed_2021_757730
crossref_primary_10_4049_jimmunol_1302611
crossref_primary_10_1016_j_smim_2015_03_004
crossref_primary_10_1155_2016_1478340
crossref_primary_10_5551_jat_20123
crossref_primary_10_1016_j_prostaglandins_2014_08_003
crossref_primary_10_3390_molecules20058072
crossref_primary_10_1016_j_cell_2012_01_026
crossref_primary_10_1016_j_tube_2012_06_004
crossref_primary_10_3389_fimmu_2020_579849
crossref_primary_10_3389_fimmu_2018_02417
crossref_primary_10_1093_nar_gkt777
crossref_primary_10_3389_fmicb_2016_00354
crossref_primary_10_1016_j_chom_2015_05_005
crossref_primary_10_1002_eji_201646349
crossref_primary_10_1111_imr_12249
crossref_primary_10_1164_rccm_201807_1361OC
crossref_primary_10_1016_j_smim_2016_10_007
crossref_primary_10_1016_S0140_6736_16_30770_X
crossref_primary_10_1242_dmm_033175
crossref_primary_10_1371_journal_pone_0149233
crossref_primary_10_1038_s41598_017_08489_7
crossref_primary_10_1093_infdis_jix050
crossref_primary_10_1016_j_cell_2013_03_022
crossref_primary_10_1016_j_smim_2013_08_006
crossref_primary_10_1109_TCBB_2023_3291134
crossref_primary_10_1093_infdis_jix052
crossref_primary_10_1093_infdis_jix051
crossref_primary_10_1155_2012_940616
crossref_primary_10_3389_fcimb_2021_619081
crossref_primary_10_1016_j_cell_2014_11_024
crossref_primary_10_2147_IDR_S291867
crossref_primary_10_1371_journal_pone_0108854
crossref_primary_10_1093_infdis_jiz110
crossref_primary_10_1038_nri3211
crossref_primary_10_1080_13880209_2016_1238949
crossref_primary_10_1038_nrd_2017_162
crossref_primary_10_1164_rccm_201806_1053PP
crossref_primary_10_1016_j_imbio_2022_152224
crossref_primary_10_1111_joim_12256
crossref_primary_10_1016_j_smim_2014_04_003
crossref_primary_10_3389_fimmu_2019_02139
crossref_primary_10_1016_S1473_3099_12_70321_3
crossref_primary_10_1016_j_prostaglandins_2013_02_004
crossref_primary_10_1073_pnas_1902596116
crossref_primary_10_1073_pnas_2002732117
crossref_primary_10_1189_jlb_4MR1114_524R
crossref_primary_10_1183_13993003_02263_2021
crossref_primary_10_3390_tropicalmed7030048
crossref_primary_10_7759_cureus_38811
crossref_primary_10_1111_raq_12719
crossref_primary_10_1186_s13578_021_00642_0
crossref_primary_10_1016_j_crimmu_2022_03_003
crossref_primary_10_1080_15548627_2019_1582743
crossref_primary_10_3389_fimmu_2021_722735
crossref_primary_10_1093_infdis_jiy712
crossref_primary_10_1111_eci_12609
crossref_primary_10_1371_journal_ppat_1005667
crossref_primary_10_1093_infdis_jiad050
crossref_primary_10_1586_1744666X_2015_985658
crossref_primary_10_1155_2014_903680
crossref_primary_10_3389_fimmu_2022_893611
crossref_primary_10_3389_fmicb_2020_00845
crossref_primary_10_1172_JCI130319
crossref_primary_10_1016_j_coph_2013_06_007
crossref_primary_10_1242_dmm_021394
crossref_primary_10_3389_fimmu_2023_1326651
crossref_primary_10_1186_s12879_016_1451_0
crossref_primary_10_1146_annurev_immunol_032712_100022
crossref_primary_10_1172_JCI175264
crossref_primary_10_1128_MMBR_00032_13
crossref_primary_10_1155_2013_781320
crossref_primary_10_1016_j_molmed_2012_10_002
crossref_primary_10_1371_journal_ppat_1005652
crossref_primary_10_1371_journal_pone_0117888
crossref_primary_10_1038_s41598_018_36696_3
crossref_primary_10_1183_16000617_0077_2017
crossref_primary_10_1038_nrdp_2016_76
crossref_primary_10_1016_j_tim_2020_09_006
crossref_primary_10_1002_biof_1691
crossref_primary_10_3389_fimmu_2023_1210372
crossref_primary_10_1016_j_medj_2020_11_003
crossref_primary_10_2217_imt_2016_0070
crossref_primary_10_4049_jimmunol_1800202
crossref_primary_10_1096_fj_12_218990
crossref_primary_10_3389_fimmu_2020_566608
crossref_primary_10_3389_fmicb_2021_757134
crossref_primary_10_1038_nri3813
crossref_primary_10_1111_imr_12273
crossref_primary_10_1111_imr_12275
crossref_primary_10_1126_scitranslmed_3007402
crossref_primary_10_1128_mbio_02764_22
crossref_primary_10_1002_emmm_201201772
crossref_primary_10_1111_iep_12191
crossref_primary_10_3389_fimmu_2016_00434
crossref_primary_10_1038_gene_2012_39
crossref_primary_10_1038_s41467_019_08405_9
crossref_primary_10_1084_jem_20230679
crossref_primary_10_3389_froh_2023_1288722
crossref_primary_10_1016_j_ejphar_2015_03_083
crossref_primary_10_1038_s41589_018_0018_3
crossref_primary_10_3389_fimmu_2022_820134
crossref_primary_10_1371_journal_ppat_1011187
crossref_primary_10_1586_eci_13_8
crossref_primary_10_1186_s12974_022_02506_x
crossref_primary_10_1371_journal_pone_0139711
crossref_primary_10_3389_fimmu_2019_02321
crossref_primary_10_3389_fimmu_2020_01094
crossref_primary_10_3389_fmicb_2018_00070
crossref_primary_10_1002_ana_26240
crossref_primary_10_1371_journal_ppat_1004770
crossref_primary_10_1016_j_celrep_2023_112177
crossref_primary_10_1038_s41423_020_0502_z
crossref_primary_10_3389_fmicb_2018_01028
crossref_primary_10_1093_cid_ciy725
crossref_primary_10_1111_resp_12052
crossref_primary_10_1093_infdis_jix319
crossref_primary_10_1093_infdis_jix317
crossref_primary_10_3389_fimmu_2017_00180
crossref_primary_10_1111_imm_12223
crossref_primary_10_1016_j_micpath_2019_03_003
crossref_primary_10_1080_15548627_2017_1339001
crossref_primary_10_1038_nri_2015_4
crossref_primary_10_3389_fimmu_2021_623941
crossref_primary_10_1016_j_chom_2012_07_009
crossref_primary_10_1016_j_eclinm_2021_100871
crossref_primary_10_1016_j_cyto_2018_07_008
crossref_primary_10_1371_journal_pone_0104414
crossref_primary_10_1016_j_smim_2017_08_006
crossref_primary_10_1371_journal_ppat_1003789
crossref_primary_10_1016_j_dci_2019_103523
crossref_primary_10_1016_j_sajb_2019_11_007
crossref_primary_10_1093_cid_civ582
crossref_primary_10_2217_fmb_2022_0026
crossref_primary_10_1002_mco2_353
crossref_primary_10_1128_msphere_00629_23
crossref_primary_10_1111_imm_13781
crossref_primary_10_1016_j_cyto_2019_154824
crossref_primary_10_1016_j_cell_2017_07_030
crossref_primary_10_1007_s13361_019_02334_z
crossref_primary_10_1189_jlb_3CE0715_319R
crossref_primary_10_1016_j_bjid_2014_10_008
crossref_primary_10_7861_clinmedicine_15_6_s43
crossref_primary_10_1016_S1473_3099_13_70328_1
crossref_primary_10_1016_S1473_3099_14_70828_X
crossref_primary_10_1016_j_mam_2017_03_005
crossref_primary_10_1128_mbio_03496_22
crossref_primary_10_1186_s12974_017_0801_1
crossref_primary_10_1186_s41479_016_0019_5
crossref_primary_10_1146_annurev_immunol_093019_010426
crossref_primary_10_1016_j_isci_2024_109135
crossref_primary_10_3389_fimmu_2018_00806
crossref_primary_10_3389_fimmu_2017_01943
crossref_primary_10_1016_j_sciaf_2023_e01985
crossref_primary_10_1016_j_tim_2019_08_005
crossref_primary_10_1186_s12883_020_01713_4
crossref_primary_10_1128_microbiolspec_TBTB2_0021_2016
crossref_primary_10_1242_dmm_016089
crossref_primary_10_12688_wellcomeopenres_15506_3
crossref_primary_10_12688_wellcomeopenres_15506_2
crossref_primary_10_1007_s00281_018_0725_6
crossref_primary_10_12688_wellcomeopenres_15506_1
crossref_primary_10_3390_ijms25042145
crossref_primary_10_1016_j_prostaglandins_2019_106398
crossref_primary_10_1016_j_vaccine_2017_04_007
crossref_primary_10_3389_fneur_2022_820168
crossref_primary_10_1016_j_prrv_2020_02_002
crossref_primary_10_3390_genes14010207
crossref_primary_10_4103_0028_3886_266232
crossref_primary_10_1007_s00281_015_0531_3
crossref_primary_10_1093_ofid_ofad379
crossref_primary_10_1371_journal_ppat_1010040
crossref_primary_10_1152_physrev_00026_2017
crossref_primary_10_7554_eLife_39123
crossref_primary_10_4049_jimmunol_1200551
crossref_primary_10_1016_j_smim_2014_10_002
crossref_primary_10_1016_j_smim_2014_10_003
crossref_primary_10_1186_s12916_016_0635_1
crossref_primary_10_1039_c3lc50099c
crossref_primary_10_1016_j_smim_2014_10_001
crossref_primary_10_3390_app10082688
crossref_primary_10_1016_j_humimm_2012_03_007
crossref_primary_10_1093_femsre_fuae011
crossref_primary_10_3389_fcimb_2014_00184
crossref_primary_10_1080_14656566_2019_1638912
crossref_primary_10_1016_j_dci_2014_02_003
crossref_primary_10_1016_j_jep_2018_12_008
crossref_primary_10_1517_17425255_2016_1121381
crossref_primary_10_1016_j_cell_2021_02_046
crossref_primary_10_1093_cid_ciz981
crossref_primary_10_1159_000358146
crossref_primary_10_3389_fimmu_2021_618569
crossref_primary_10_1007_s10072_021_05693_2
crossref_primary_10_3390_pharmaceutics14081745
crossref_primary_10_1371_journal_pone_0181942
crossref_primary_10_1016_j_jrid_2020_07_005
crossref_primary_10_15789_2220_7619_MBM_1947
crossref_primary_10_1016_j_cell_2022_10_025
crossref_primary_10_1016_j_it_2022_03_011
crossref_primary_10_1038_nrneurol_2017_120
crossref_primary_10_1093_jpids_piy084
crossref_primary_10_1016_j_yapd_2015_04_001
crossref_primary_10_1016_j_tube_2016_09_008
crossref_primary_10_1128_mBio_00342_16
crossref_primary_10_1126_science_abh2841
crossref_primary_10_3390_ijms24021203
crossref_primary_10_1038_nature13479
crossref_primary_10_1073_pnas_2024852118
crossref_primary_10_1016_j_dci_2014_01_020
crossref_primary_10_1016_j_cyto_2019_154759
crossref_primary_10_1016_S1473_3099_13_70009_4
crossref_primary_10_1080_21505594_2017_1377881
crossref_primary_10_1016_j_ebiom_2016_02_016
crossref_primary_10_1038_nm_4073
crossref_primary_10_1016_j_tube_2015_12_002
crossref_primary_10_1242_dmm_010843
crossref_primary_10_1111_febs_16209
crossref_primary_10_1371_journal_pone_0064748
crossref_primary_10_1080_14728222_2019_1691525
crossref_primary_10_1016_j_ijid_2014_12_030
crossref_primary_10_1242_dmm_050189
crossref_primary_10_12688_wellcomeopenres_14007_1
crossref_primary_10_3389_fcimb_2022_827528
crossref_primary_10_1586_17512433_2016_1155447
crossref_primary_10_3390_ijms18112375
crossref_primary_10_1002_JLB_MR0318_102R
crossref_primary_10_1371_journal_ppat_1003946
crossref_primary_10_3390_microorganisms7120650
crossref_primary_10_3389_fimmu_2018_02094
crossref_primary_10_1080_17476348_2018_1515628
crossref_primary_10_1128_mSphere_00263_20
crossref_primary_10_1016_j_cyto_2019_154897
crossref_primary_10_1042_CS20150021
crossref_primary_10_1016_j_cell_2019_08_004
crossref_primary_10_1016_j_meegid_2014_06_025
crossref_primary_10_3389_fphar_2022_781889
crossref_primary_10_1016_S1474_4422_13_70168_6
crossref_primary_10_1016_j_cytogfr_2013_12_005
crossref_primary_10_2174_1389201019666180731120544
crossref_primary_10_1093_infdis_jit494
crossref_primary_10_1098_rstb_2013_0437
crossref_primary_10_1002_path_4187
crossref_primary_10_12688_wellcomeopenres_15573_1
crossref_primary_10_1038_nature12111
crossref_primary_10_1038_nprot_2013_068
crossref_primary_10_1002_jcp_27555
crossref_primary_10_1371_journal_ppat_1011559
Cites_doi 10.1056/NEJMoa040573
10.1002/0471142735.im1426s95
10.1016/j.cell.2010.02.013
10.1177/0883073811398132
10.1016/j.molimm.2011.01.015
10.1084/jem.20080767
10.1056/NEJMp048227
10.1038/nature08123
10.1016/j.immuni.2009.10.007
10.1378/chest.107.6.1621
10.1073/pnas.81.11.3501
10.1086/430914
10.1038/ni.1904
10.1126/scisignal.3115re4
10.1016/S1074-7613(02)00475-2
10.1016/j.cell.2010.02.030
10.1086/427995
10.1111/j.1462-5822.2008.01133.x
10.1073/pnas.92.21.9475
10.1016/j.immuni.2008.06.011
10.1056/NEJM198107163050312
10.1021/bi00076a002
10.1074/jbc.R400027200
10.1038/ng2142
10.1128/CMR.00042-10
10.1086/429317
10.1146/annurev.immunol.25.022106.141647
10.1128/AAC.00064-11
10.1086/378642
10.1038/nature09534
10.4049/jimmunol.181.7.5071
10.4049/jimmunol.0900477
10.1074/jbc.271.3.1329
10.1016/S0140-6736(74)91639-0
10.1016/j.ceb.2009.12.003
10.4049/jimmunol.170.12.6266
10.1016/j.tube.2010.11.001
10.1172/JCI23949
10.1016/S0140-6736(84)90478-1
10.1016/j.jns.2010.03.025
10.1542/peds.99.2.226
10.1002/0471729256.mc10b02s3
10.1126/science.2820055
10.1016/j.cell.2011.02.022
10.1146/annurev.genom.8.080706.092315
10.1016/j.trstmh.2008.01.004
10.1128/IAI.02061-05
10.1126/science.1179663
ContentType Journal Article
Copyright 2012 Elsevier Inc.
Copyright © 2012 Elsevier Inc. All rights reserved.
2012 Elsevier Inc. All rights reserved. 2012
Copyright_xml – notice: 2012 Elsevier Inc.
– notice: Copyright © 2012 Elsevier Inc. All rights reserved.
– notice: 2012 Elsevier Inc. All rights reserved. 2012
DBID 6I.
AAFTH
FBQ
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7QL
C1K
5PM
DOI 10.1016/j.cell.2011.12.023
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
AGRIS
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
DatabaseTitleList Bacteriology Abstracts (Microbiology B)


MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1097-4172
EndPage 446
ExternalDocumentID 10_1016_j_cell_2011_12_023
22304914
US201600009310
S0092867412000104
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIH HHS
  grantid: DP2 OD008614-01
– fundername: NIMH NIH HHS
  grantid: DP1 MH099901
– fundername: NIAID NIH HHS
  grantid: R01 AI054503-07
– fundername: NIH HHS
  grantid: DP2 OD008614
– fundername: NIAID NIH HHS
  grantid: R01 AI054503
– fundername: NIAID NIH HHS
  grantid: R37 AI054503
– fundername: National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID
  grantid: R01 AI054503-07 || AI
GroupedDBID ---
--K
-DZ
-ET
-~X
0R~
0WA
1RT
1~5
29B
2FS
2WC
3EH
4.4
457
4G.
53G
5GY
5RE
5VS
62-
6I.
6J9
7-5
85S
9M8
AACTN
AAEDT
AAEDW
AAFTH
AAFWJ
AAIAV
AAIKJ
AAKRW
AAKUH
AAQFI
AAUCE
AAVLU
AAXJY
AAXUO
AAYJJ
ABCQX
ABJNI
ABMAC
ABMWF
ABOCM
ABTAH
ABVKL
ACGFO
ACGFS
ACNCT
ADBBV
ADEZE
ADJPV
AEFWE
AENEX
AEXQZ
AFDAS
AFTJW
AGHFR
AGHSJ
AGKMS
AHHHB
AIDAL
AITUG
ALKID
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ASPBG
AVWKF
AZFZN
BAWUL
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FCP
FDB
FIRID
HH5
HZ~
IH2
IHE
IXB
J1W
JIG
K-O
KOO
KQ8
L7B
LX5
M3Z
M41
N9A
NCXOZ
O-L
O9-
OK1
P2P
RCE
RIG
RNS
ROL
RPZ
SCP
SDG
SDP
SES
SSZ
TAE
TN5
TR2
TWZ
UKR
UPT
VQA
WH7
WQ6
YYQ
YZZ
ZA5
ZCA
ZY4
.-4
.55
.GJ
.HR
1CY
1VV
2KS
3O-
6TJ
AALRI
AAQXK
ABEFU
ABPTK
ADMUD
AEQTP
AETEA
AI.
FBQ
FEDTE
FGOYB
G-2
G8K
HVGLF
H~9
MVM
OHT
OMK
OZT
PUQ
R2-
UBW
UHB
VH1
X7M
XFK
YYP
ZGI
ZHY
ZKB
0SF
AAHBH
AAMRU
ADVLN
AKAPO
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ABDPE
ACRPL
ADNMO
CITATION
7X8
7QL
C1K
5PM
ID FETCH-LOGICAL-c576t-3bfa2321820487d6183d5093b2d03fe1141fc24e2f09a8b8cd940edfdd954d43
IEDL.DBID ABVKL
ISSN 0092-8674
IngestDate Tue Sep 17 21:28:02 EDT 2024
Fri Oct 25 09:43:22 EDT 2024
Sat Oct 26 05:03:32 EDT 2024
Fri Dec 06 02:39:14 EST 2024
Sat Nov 02 12:31:03 EDT 2024
Wed Dec 27 19:12:13 EST 2023
Fri Feb 23 02:28:08 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
Copyright © 2012 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c576t-3bfa2321820487d6183d5093b2d03fe1141fc24e2f09a8b8cd940edfdd954d43
Notes http://dx.doi.org/10.1016/j.cell.2011.12.023
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0092867412000104
PMID 22304914
PQID 920231372
PQPubID 23479
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3433720
proquest_miscellaneous_968167898
proquest_miscellaneous_920231372
crossref_primary_10_1016_j_cell_2011_12_023
pubmed_primary_22304914
fao_agris_US201600009310
elsevier_sciencedirect_doi_10_1016_j_cell_2011_12_023
PublicationCentury 2000
PublicationDate 2012-02-03
PublicationDateYYYYMMDD 2012-02-03
PublicationDate_xml – month: 02
  year: 2012
  text: 2012-02-03
  day: 03
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cell
PublicationTitleAlternate Cell
PublicationYear 2012
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Samuelsson, Dahlen, Lindgren, Rouzer, Serhan (bib32) 1987; 237
Behr, Schurr, Gros (bib5) 2010; 140
Desvignes, Ernst (bib12) 2009; 31
Ariel, Chiang, Arita, Petasis, Serhan (bib2) 2003; 170
Bafica, Scanga, Serhan, Machado, White, Sher, Aliberti (bib4) 2005; 115
Serhan, Ward, Gilroy (bib35) 2010
Vandenabeele, Declercq, Van Herreweghe, Vanden Berghe (bib42) 2010; 3
Mayosi, Ntsekhe, Volmink, Commerford (bib25) 2002
Mayanja-Kizza, Jones-Lopez, Okwera, Wallis, Ellner, Mugerwa, Whalen (bib24) 2005; 191
Schoeman, J.F., Janse van Rensburg, A., Laubscher, J.A., and Springer, P. (2011). The Role of Aspirin in Childhood Tuberculous Meningitis. Journal of child neurology.
Misra, Kalita, Nair (bib26) 2010; 293
Haeggstrom (bib18) 2004; 279
Markman, Eagleton (bib23) 1981; 305
Tobin, Vary, Ray, Walsh, Dunstan, Bang, Hagge, Khadge, King, Hawn (bib41) 2010; 140
Wallis, R.S. (2005). Reconsidering adjuvant immunotherapy for tuberculosis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America
Claria, Serhan (bib9) 1995; 92
Chen, Divangahi, Gan, Shin, Hong, Lee, Serhan, Behar, Remold (bib7) 2008; 205
Clay, Volkman, Ramakrishnan (bib10) 2008; 29
Hawkey, Yap, Pereira, Moore, Davidson, Pasvol, Kon, Wall, Wilkinson (bib19) 2005; 40
Tobin, Ramakrishnan (bib40) 2008; 10
Christofferson, Yuan (bib8) 2010; 22
Roca, Mulero, Lopez-Munoz, Sepulcre, Renshaw, Meseguer, Mulero (bib31) 2008; 181
201-208.
Morris, Stables, Hobbs, de Souza, Colville-Nash, Warner, Newson, Bellingan, Gilroy (bib27) 2009; 183
Volkman, Pozos, Zheng, Davis, Rawls, Ramakrishnan (bib43) 2010; 327
Goldman, Welbourn, Kobzik, Valeri, Shepro, Hechtman (bib17) 1993; 113
Muthuswamy, Hu, Carasso, Antonio, Dandamudi (bib28) 1995; 107
Schoeman, Van Zyl, Laubscher, Donald (bib34) 1997; 99
Durbin, Abecasis, Altshuler, Auton, Brooks, Gibbs, Hurles, McVean (bib15) 2010; 467
Lawn, Zumla (bib22) 2011
Thwaites, Nguyen, Nguyen, Hoang, Do, Nguyen, Nguyen, Nguyen, Nguyen, Nguyen (bib39) 2004; 351
Fortin, Abel, Casanova, Gros (bib16) 2007; 8
Chambers, Hendrickse, Record, Rudge, Smith (bib6) 1984; 2
Curtis, Kopanitsa, Stebbings, Speirs, Ignatyeva, Balabanova, Nikolayevskyy, Hoffner, Horstmann, Drobniewski (bib11) 2011; 91
Prasad, Singh (bib30) 2008
Kwan, Ernst (bib21) 2011; 24
Donald, Schoeman (bib14) 2004; 351
Payan, Missirian-Bastian, Goetzl (bib29) 1984; 81
Agarwal, Lamichhane, Gupta, Nolan, Bishai (bib1) 2009; 460
Divangahi, Desjardins, Nunes-Alves, Remold, Behar (bib13) 2010; 11
Stranger, Nica, Forrest, Dimas, Bird, Beazley, Ingle, Dunning, Flicek, Koller (bib38) 2007; 39
Serhan, Fiore, Brezinski, Lynch (bib37) 1993; 32
Kahawita, Lockwood (bib20) 2008; 102
Auerbach, Bisgaier, Wolle, Saxena (bib3) 1996; 271
Serhan (bib36) 2007; 25
22304907 - Cell. 2012 Feb 3;148(3):389-91. doi: 10.1016/j.cell.2012.01.026
Kwan (10.1016/j.cell.2011.12.023_bib21) 2011; 24
Chambers (10.1016/j.cell.2011.12.023_bib6) 1984; 2
Hawkey (10.1016/j.cell.2011.12.023_bib19) 2005; 40
Schoeman (10.1016/j.cell.2011.12.023_bib34) 1997; 99
Serhan (10.1016/j.cell.2011.12.023_bib37) 1993; 32
Muthuswamy (10.1016/j.cell.2011.12.023_bib28) 1995; 107
Roca (10.1016/j.cell.2011.12.023_bib31) 2008; 181
Thwaites (10.1016/j.cell.2011.12.023_bib39) 2004; 351
Mayosi (10.1016/j.cell.2011.12.023_bib25) 2002
Tobin (10.1016/j.cell.2011.12.023_bib40) 2008; 10
Mayanja-Kizza (10.1016/j.cell.2011.12.023_bib24) 2005; 191
Agarwal (10.1016/j.cell.2011.12.023_bib1) 2009; 460
Volkman (10.1016/j.cell.2011.12.023_bib43) 2010; 327
10.1016/j.cell.2011.12.023_bib33
Misra (10.1016/j.cell.2011.12.023_bib26) 2010; 293
Serhan (10.1016/j.cell.2011.12.023_bib35) 2010
Samuelsson (10.1016/j.cell.2011.12.023_bib32) 1987; 237
10.1016/j.cell.2011.12.023_bib50
Bafica (10.1016/j.cell.2011.12.023_bib4) 2005; 115
Durbin (10.1016/j.cell.2011.12.023_bib15) 2010; 467
Divangahi (10.1016/j.cell.2011.12.023_bib13) 2010; 11
Fortin (10.1016/j.cell.2011.12.023_bib16) 2007; 8
Behr (10.1016/j.cell.2011.12.023_bib5) 2010; 140
Curtis (10.1016/j.cell.2011.12.023_bib11) 2011; 91
Desvignes (10.1016/j.cell.2011.12.023_bib12) 2009; 31
10.1016/j.cell.2011.12.023_bib48
Prasad (10.1016/j.cell.2011.12.023_bib30) 2008
10.1016/j.cell.2011.12.023_bib49
Chen (10.1016/j.cell.2011.12.023_bib7) 2008; 205
10.1016/j.cell.2011.12.023_bib46
Payan (10.1016/j.cell.2011.12.023_bib29) 1984; 81
10.1016/j.cell.2011.12.023_bib47
10.1016/j.cell.2011.12.023_bib44
10.1016/j.cell.2011.12.023_bib45
Auerbach (10.1016/j.cell.2011.12.023_bib3) 1996; 271
Tobin (10.1016/j.cell.2011.12.023_bib41) 2010; 140
Serhan (10.1016/j.cell.2011.12.023_bib36) 2007; 25
Vandenabeele (10.1016/j.cell.2011.12.023_bib42) 2010; 3
Kahawita (10.1016/j.cell.2011.12.023_bib20) 2008; 102
Donald (10.1016/j.cell.2011.12.023_bib14) 2004; 351
Goldman (10.1016/j.cell.2011.12.023_bib17) 1993; 113
Haeggstrom (10.1016/j.cell.2011.12.023_bib18) 2004; 279
Lawn (10.1016/j.cell.2011.12.023_bib22) 2011
Claria (10.1016/j.cell.2011.12.023_bib9) 1995; 92
Stranger (10.1016/j.cell.2011.12.023_bib38) 2007; 39
10.1016/j.cell.2011.12.023_bib57
Christofferson (10.1016/j.cell.2011.12.023_bib8) 2010; 22
Clay (10.1016/j.cell.2011.12.023_bib10) 2008; 29
10.1016/j.cell.2011.12.023_bib58
Ariel (10.1016/j.cell.2011.12.023_bib2) 2003; 170
10.1016/j.cell.2011.12.023_bib55
10.1016/j.cell.2011.12.023_bib56
Markman (10.1016/j.cell.2011.12.023_bib23) 1981; 305
Morris (10.1016/j.cell.2011.12.023_bib27) 2009; 183
10.1016/j.cell.2011.12.023_bib53
10.1016/j.cell.2011.12.023_bib54
10.1016/j.cell.2011.12.023_bib51
10.1016/j.cell.2011.12.023_bib52
References_xml – year: 2010
  ident: bib35
  article-title: Fundamentals of Inflammation
  contributor:
    fullname: Gilroy
– volume: 140
  start-page: 615
  year: 2010
  end-page: 618
  ident: bib5
  article-title: TB: screening for responses to a vile visitor
  publication-title: Cell
  contributor:
    fullname: Gros
– volume: 279
  start-page: 50639
  year: 2004
  end-page: 50642
  ident: bib18
  article-title: Leukotriene A4 hydrolase/aminopeptidase, the gatekeeper of chemotactic leukotriene B4 biosynthesis
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Haeggstrom
– start-page: CD000526
  year: 2002
  ident: bib25
  article-title: Interventions for treating tuberculous pericarditis
  publication-title: Cochrane Database Syst. Rev.
  contributor:
    fullname: Commerford
– volume: 99
  start-page: 226
  year: 1997
  end-page: 231
  ident: bib34
  article-title: Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis
  publication-title: Pediatrics
  contributor:
    fullname: Donald
– volume: 191
  start-page: 856
  year: 2005
  end-page: 865
  ident: bib24
  article-title: Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda
  publication-title: J. Infect. Dis.
  contributor:
    fullname: Whalen
– volume: 460
  start-page: 98
  year: 2009
  end-page: 102
  ident: bib1
  article-title: Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase
  publication-title: Nature
  contributor:
    fullname: Bishai
– volume: 271
  start-page: 1329
  year: 1996
  end-page: 1335
  ident: bib3
  article-title: Oxidation of low density lipoproteins greatly enhances their association with lipoprotein lipase anchored to endothelial cell matrix
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Saxena
– volume: 39
  start-page: 1217
  year: 2007
  end-page: 1224
  ident: bib38
  article-title: Population genomics of human gene expression
  publication-title: Nat. Genet.
  contributor:
    fullname: Koller
– volume: 29
  start-page: 283
  year: 2008
  end-page: 294
  ident: bib10
  article-title: Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death
  publication-title: Immunity
  contributor:
    fullname: Ramakrishnan
– volume: 351
  start-page: 1741
  year: 2004
  end-page: 1751
  ident: bib39
  article-title: Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults
  publication-title: N. Engl. J. Med.
  contributor:
    fullname: Nguyen
– volume: 92
  start-page: 9475
  year: 1995
  end-page: 9479
  ident: bib9
  article-title: Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions
  publication-title: Proc. Natl. Acad. Sci. USA
  contributor:
    fullname: Serhan
– volume: 113
  start-page: 297
  year: 1993
  end-page: 303
  ident: bib17
  article-title: Lavage with leukotriene B4 induces lung generation of tumor necrosis factor-alpha that in turn mediates neutrophil diapedesis
  publication-title: Surgery
  contributor:
    fullname: Hechtman
– volume: 115
  start-page: 1601
  year: 2005
  end-page: 1606
  ident: bib4
  article-title: Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production
  publication-title: J. Clin. Invest.
  contributor:
    fullname: Aliberti
– volume: 11
  start-page: 751
  year: 2010
  end-page: 758
  ident: bib13
  article-title: Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis
  publication-title: Nat. Immunol.
  contributor:
    fullname: Behar
– volume: 327
  start-page: 466
  year: 2010
  end-page: 469
  ident: bib43
  article-title: Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium
  publication-title: Science
  contributor:
    fullname: Ramakrishnan
– volume: 2
  start-page: 181
  year: 1984
  end-page: 184
  ident: bib6
  article-title: Paradoxical expansion of intracranial tuberculomas during chemotherapy
  publication-title: Lancet
  contributor:
    fullname: Smith
– volume: 91
  start-page: 22
  year: 2011
  end-page: 25
  ident: bib11
  article-title: Association analysis of the LTA4H gene polymorphisms and pulmonary tuberculosis in 9115 subjects
  publication-title: Tuberculosis (Edinb.)
  contributor:
    fullname: Drobniewski
– volume: 25
  start-page: 101
  year: 2007
  end-page: 137
  ident: bib36
  article-title: Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways
  publication-title: Annu. Rev. Immunol.
  contributor:
    fullname: Serhan
– volume: 40
  start-page: 1368
  year: 2005
  end-page: 1371
  ident: bib19
  article-title: Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis
  publication-title: Clin. Infect. Dis.
  contributor:
    fullname: Wilkinson
– volume: 32
  start-page: 6313
  year: 1993
  end-page: 6319
  ident: bib37
  article-title: Lipoxin A4 metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products
  publication-title: Biochemistry
  contributor:
    fullname: Lynch
– volume: 107
  start-page: 1621
  year: 1995
  end-page: 1630
  ident: bib28
  article-title: Prednisone as adjunctive therapy in the management of pulmonary tuberculosis. Report of 12 cases and review of the literature
  publication-title: Chest
  contributor:
    fullname: Dandamudi
– volume: 140
  start-page: 717
  year: 2010
  end-page: 730
  ident: bib41
  article-title: The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans
  publication-title: Cell
  contributor:
    fullname: Hawn
– volume: 24
  start-page: 351
  year: 2011
  end-page: 376
  ident: bib21
  article-title: HIV and Tuberculosis: a Deadly Human Syndemic
  publication-title: Clin. Microbiol. Rev.
  contributor:
    fullname: Ernst
– volume: 305
  start-page: 167
  year: 1981
  ident: bib23
  article-title: Paradoxical clinical improvement and radiographic deterioration in anergic patients treated for far advanced tuberculosis
  publication-title: N. Engl. J. Med.
  contributor:
    fullname: Eagleton
– start-page: CD002244
  year: 2008
  ident: bib30
  article-title: Corticosteroids for managing tuberculous meningitis
  publication-title: Cochrane Database Syst. Rev.
  contributor:
    fullname: Singh
– volume: 237
  start-page: 1171
  year: 1987
  end-page: 1176
  ident: bib32
  article-title: Leukotrienes and lipoxins: structures, biosynthesis, and biological effects
  publication-title: Science
  contributor:
    fullname: Serhan
– volume: 22
  start-page: 263
  year: 2010
  end-page: 268
  ident: bib8
  article-title: Necroptosis as an alternative form of programmed cell death
  publication-title: Curr. Opin. Cell Biol.
  contributor:
    fullname: Yuan
– year: 2011
  ident: bib22
  article-title: Tuberculosis
  contributor:
    fullname: Zumla
– volume: 10
  start-page: 1027
  year: 2008
  end-page: 1039
  ident: bib40
  article-title: Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis
  publication-title: Cell. Microbiol.
  contributor:
    fullname: Ramakrishnan
– volume: 351
  start-page: 1719
  year: 2004
  end-page: 1720
  ident: bib14
  article-title: Tuberculous meningitis
  publication-title: N. Engl. J. Med.
  contributor:
    fullname: Schoeman
– volume: 3
  start-page: re4
  year: 2010
  ident: bib42
  article-title: The role of the kinases RIP1 and RIP3 in TNF-induced necrosis
  publication-title: Sci. Signal.
  contributor:
    fullname: Vanden Berghe
– volume: 102
  start-page: 329
  year: 2008
  end-page: 337
  ident: bib20
  article-title: Towards understanding the pathology of erythema nodosum leprosum
  publication-title: Trans. R. Soc. Trop. Med. Hyg.
  contributor:
    fullname: Lockwood
– volume: 81
  start-page: 3501
  year: 1984
  end-page: 3505
  ident: bib29
  article-title: Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4
  publication-title: Proc. Natl. Acad. Sci. USA
  contributor:
    fullname: Goetzl
– volume: 293
  start-page: 12
  year: 2010
  end-page: 17
  ident: bib26
  article-title: Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial
  publication-title: J. Neurol. Sci.
  contributor:
    fullname: Nair
– volume: 31
  start-page: 974
  year: 2009
  end-page: 985
  ident: bib12
  article-title: Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis
  publication-title: Immunity
  contributor:
    fullname: Ernst
– volume: 8
  start-page: 163
  year: 2007
  end-page: 192
  ident: bib16
  article-title: Host genetics of mycobacterial diseases in mice and men: forward genetic studies of BCG-osis and tuberculosis
  publication-title: Annu. Rev. Genomics Hum. Genet.
  contributor:
    fullname: Gros
– volume: 170
  start-page: 6266
  year: 2003
  end-page: 6272
  ident: bib2
  article-title: Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells
  publication-title: J. Immunol.
  contributor:
    fullname: Serhan
– volume: 467
  start-page: 1061
  year: 2010
  end-page: 1073
  ident: bib15
  article-title: A map of human genome variation from population-scale sequencing
  publication-title: Nature
  contributor:
    fullname: McVean
– volume: 181
  start-page: 5071
  year: 2008
  end-page: 5081
  ident: bib31
  article-title: Evolution of the inflammatory response in vertebrates: fish TNF-alpha is a powerful activator of endothelial cells but hardly activates phagocytes
  publication-title: J. Immunol.
  contributor:
    fullname: Mulero
– volume: 205
  start-page: 2791
  year: 2008
  end-page: 2801
  ident: bib7
  article-title: Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death
  publication-title: J. Exp. Med.
  contributor:
    fullname: Remold
– volume: 183
  start-page: 2089
  year: 2009
  end-page: 2096
  ident: bib27
  article-title: Effects of low-dose aspirin on acute inflammatory responses in humans
  publication-title: J. Immunol.
  contributor:
    fullname: Gilroy
– volume: 351
  start-page: 1741
  year: 2004
  ident: 10.1016/j.cell.2011.12.023_bib39
  article-title: Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa040573
  contributor:
    fullname: Thwaites
– ident: 10.1016/j.cell.2011.12.023_bib58
  doi: 10.1002/0471142735.im1426s95
– ident: 10.1016/j.cell.2011.12.023_bib57
  doi: 10.1016/j.cell.2010.02.013
– ident: 10.1016/j.cell.2011.12.023_bib45
– ident: 10.1016/j.cell.2011.12.023_bib33
  doi: 10.1177/0883073811398132
– ident: 10.1016/j.cell.2011.12.023_bib50
  doi: 10.1016/j.molimm.2011.01.015
– volume: 205
  start-page: 2791
  year: 2008
  ident: 10.1016/j.cell.2011.12.023_bib7
  article-title: Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20080767
  contributor:
    fullname: Chen
– start-page: CD002244
  year: 2008
  ident: 10.1016/j.cell.2011.12.023_bib30
  article-title: Corticosteroids for managing tuberculous meningitis
  publication-title: Cochrane Database Syst. Rev.
  contributor:
    fullname: Prasad
– volume: 351
  start-page: 1719
  year: 2004
  ident: 10.1016/j.cell.2011.12.023_bib14
  article-title: Tuberculous meningitis
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMp048227
  contributor:
    fullname: Donald
– volume: 460
  start-page: 98
  year: 2009
  ident: 10.1016/j.cell.2011.12.023_bib1
  article-title: Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase
  publication-title: Nature
  doi: 10.1038/nature08123
  contributor:
    fullname: Agarwal
– year: 2010
  ident: 10.1016/j.cell.2011.12.023_bib35
  contributor:
    fullname: Serhan
– volume: 113
  start-page: 297
  year: 1993
  ident: 10.1016/j.cell.2011.12.023_bib17
  article-title: Lavage with leukotriene B4 induces lung generation of tumor necrosis factor-alpha that in turn mediates neutrophil diapedesis
  publication-title: Surgery
  contributor:
    fullname: Goldman
– volume: 31
  start-page: 974
  year: 2009
  ident: 10.1016/j.cell.2011.12.023_bib12
  article-title: Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis
  publication-title: Immunity
  doi: 10.1016/j.immuni.2009.10.007
  contributor:
    fullname: Desvignes
– volume: 107
  start-page: 1621
  year: 1995
  ident: 10.1016/j.cell.2011.12.023_bib28
  article-title: Prednisone as adjunctive therapy in the management of pulmonary tuberculosis. Report of 12 cases and review of the literature
  publication-title: Chest
  doi: 10.1378/chest.107.6.1621
  contributor:
    fullname: Muthuswamy
– volume: 81
  start-page: 3501
  year: 1984
  ident: 10.1016/j.cell.2011.12.023_bib29
  article-title: Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.81.11.3501
  contributor:
    fullname: Payan
– ident: 10.1016/j.cell.2011.12.023_bib44
  doi: 10.1086/430914
– volume: 11
  start-page: 751
  year: 2010
  ident: 10.1016/j.cell.2011.12.023_bib13
  article-title: Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.1904
  contributor:
    fullname: Divangahi
– volume: 3
  start-page: re4
  year: 2010
  ident: 10.1016/j.cell.2011.12.023_bib42
  article-title: The role of the kinases RIP1 and RIP3 in TNF-induced necrosis
  publication-title: Sci. Signal.
  doi: 10.1126/scisignal.3115re4
  contributor:
    fullname: Vandenabeele
– ident: 10.1016/j.cell.2011.12.023_bib49
  doi: 10.1016/S1074-7613(02)00475-2
– volume: 140
  start-page: 615
  year: 2010
  ident: 10.1016/j.cell.2011.12.023_bib5
  article-title: TB: screening for responses to a vile visitor
  publication-title: Cell
  doi: 10.1016/j.cell.2010.02.030
  contributor:
    fullname: Behr
– volume: 191
  start-page: 856
  year: 2005
  ident: 10.1016/j.cell.2011.12.023_bib24
  article-title: Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda
  publication-title: J. Infect. Dis.
  doi: 10.1086/427995
  contributor:
    fullname: Mayanja-Kizza
– volume: 10
  start-page: 1027
  year: 2008
  ident: 10.1016/j.cell.2011.12.023_bib40
  article-title: Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis
  publication-title: Cell. Microbiol.
  doi: 10.1111/j.1462-5822.2008.01133.x
  contributor:
    fullname: Tobin
– volume: 92
  start-page: 9475
  year: 1995
  ident: 10.1016/j.cell.2011.12.023_bib9
  article-title: Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.92.21.9475
  contributor:
    fullname: Claria
– volume: 29
  start-page: 283
  year: 2008
  ident: 10.1016/j.cell.2011.12.023_bib10
  article-title: Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death
  publication-title: Immunity
  doi: 10.1016/j.immuni.2008.06.011
  contributor:
    fullname: Clay
– volume: 305
  start-page: 167
  year: 1981
  ident: 10.1016/j.cell.2011.12.023_bib23
  article-title: Paradoxical clinical improvement and radiographic deterioration in anergic patients treated for far advanced tuberculosis
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM198107163050312
  contributor:
    fullname: Markman
– volume: 32
  start-page: 6313
  year: 1993
  ident: 10.1016/j.cell.2011.12.023_bib37
  article-title: Lipoxin A4 metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products
  publication-title: Biochemistry
  doi: 10.1021/bi00076a002
  contributor:
    fullname: Serhan
– volume: 279
  start-page: 50639
  year: 2004
  ident: 10.1016/j.cell.2011.12.023_bib18
  article-title: Leukotriene A4 hydrolase/aminopeptidase, the gatekeeper of chemotactic leukotriene B4 biosynthesis
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.R400027200
  contributor:
    fullname: Haeggstrom
– volume: 39
  start-page: 1217
  year: 2007
  ident: 10.1016/j.cell.2011.12.023_bib38
  article-title: Population genomics of human gene expression
  publication-title: Nat. Genet.
  doi: 10.1038/ng2142
  contributor:
    fullname: Stranger
– volume: 24
  start-page: 351
  year: 2011
  ident: 10.1016/j.cell.2011.12.023_bib21
  article-title: HIV and Tuberculosis: a Deadly Human Syndemic
  publication-title: Clin. Microbiol. Rev.
  doi: 10.1128/CMR.00042-10
  contributor:
    fullname: Kwan
– volume: 40
  start-page: 1368
  year: 2005
  ident: 10.1016/j.cell.2011.12.023_bib19
  article-title: Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis
  publication-title: Clin. Infect. Dis.
  doi: 10.1086/429317
  contributor:
    fullname: Hawkey
– volume: 25
  start-page: 101
  year: 2007
  ident: 10.1016/j.cell.2011.12.023_bib36
  article-title: Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.immunol.25.022106.141647
  contributor:
    fullname: Serhan
– ident: 10.1016/j.cell.2011.12.023_bib54
  doi: 10.1128/AAC.00064-11
– ident: 10.1016/j.cell.2011.12.023_bib56
  doi: 10.1086/378642
– volume: 467
  start-page: 1061
  year: 2010
  ident: 10.1016/j.cell.2011.12.023_bib15
  article-title: A map of human genome variation from population-scale sequencing
  publication-title: Nature
  doi: 10.1038/nature09534
  contributor:
    fullname: Durbin
– volume: 181
  start-page: 5071
  year: 2008
  ident: 10.1016/j.cell.2011.12.023_bib31
  article-title: Evolution of the inflammatory response in vertebrates: fish TNF-alpha is a powerful activator of endothelial cells but hardly activates phagocytes
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.181.7.5071
  contributor:
    fullname: Roca
– ident: 10.1016/j.cell.2011.12.023_bib51
  doi: 10.4049/jimmunol.181.7.5071
– volume: 183
  start-page: 2089
  year: 2009
  ident: 10.1016/j.cell.2011.12.023_bib27
  article-title: Effects of low-dose aspirin on acute inflammatory responses in humans
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0900477
  contributor:
    fullname: Morris
– volume: 271
  start-page: 1329
  year: 1996
  ident: 10.1016/j.cell.2011.12.023_bib3
  article-title: Oxidation of low density lipoproteins greatly enhances their association with lipoprotein lipase anchored to endothelial cell matrix
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.271.3.1329
  contributor:
    fullname: Auerbach
– ident: 10.1016/j.cell.2011.12.023_bib53
  doi: 10.1016/S0140-6736(74)91639-0
– volume: 22
  start-page: 263
  year: 2010
  ident: 10.1016/j.cell.2011.12.023_bib8
  article-title: Necroptosis as an alternative form of programmed cell death
  publication-title: Curr. Opin. Cell Biol.
  doi: 10.1016/j.ceb.2009.12.003
  contributor:
    fullname: Christofferson
– volume: 170
  start-page: 6266
  year: 2003
  ident: 10.1016/j.cell.2011.12.023_bib2
  article-title: Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.170.12.6266
  contributor:
    fullname: Ariel
– ident: 10.1016/j.cell.2011.12.023_bib52
  doi: 10.1038/ng2142
– volume: 91
  start-page: 22
  year: 2011
  ident: 10.1016/j.cell.2011.12.023_bib11
  article-title: Association analysis of the LTA4H gene polymorphisms and pulmonary tuberculosis in 9115 subjects
  publication-title: Tuberculosis (Edinb.)
  doi: 10.1016/j.tube.2010.11.001
  contributor:
    fullname: Curtis
– volume: 115
  start-page: 1601
  year: 2005
  ident: 10.1016/j.cell.2011.12.023_bib4
  article-title: Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI23949
  contributor:
    fullname: Bafica
– volume: 140
  start-page: 717
  year: 2010
  ident: 10.1016/j.cell.2011.12.023_bib41
  article-title: The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans
  publication-title: Cell
  doi: 10.1016/j.cell.2010.02.013
  contributor:
    fullname: Tobin
– volume: 2
  start-page: 181
  year: 1984
  ident: 10.1016/j.cell.2011.12.023_bib6
  article-title: Paradoxical expansion of intracranial tuberculomas during chemotherapy
  publication-title: Lancet
  doi: 10.1016/S0140-6736(84)90478-1
  contributor:
    fullname: Chambers
– volume: 293
  start-page: 12
  year: 2010
  ident: 10.1016/j.cell.2011.12.023_bib26
  article-title: Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial
  publication-title: J. Neurol. Sci.
  doi: 10.1016/j.jns.2010.03.025
  contributor:
    fullname: Misra
– volume: 99
  start-page: 226
  year: 1997
  ident: 10.1016/j.cell.2011.12.023_bib34
  article-title: Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis
  publication-title: Pediatrics
  doi: 10.1542/peds.99.2.226
  contributor:
    fullname: Schoeman
– ident: 10.1016/j.cell.2011.12.023_bib47
  doi: 10.1002/0471729256.mc10b02s3
– volume: 237
  start-page: 1171
  year: 1987
  ident: 10.1016/j.cell.2011.12.023_bib32
  article-title: Leukotrienes and lipoxins: structures, biosynthesis, and biological effects
  publication-title: Science
  doi: 10.1126/science.2820055
  contributor:
    fullname: Samuelsson
– ident: 10.1016/j.cell.2011.12.023_bib46
  doi: 10.1016/j.cell.2011.02.022
– ident: 10.1016/j.cell.2011.12.023_bib55
  doi: 10.1056/NEJMoa040573
– volume: 8
  start-page: 163
  year: 2007
  ident: 10.1016/j.cell.2011.12.023_bib16
  article-title: Host genetics of mycobacterial diseases in mice and men: forward genetic studies of BCG-osis and tuberculosis
  publication-title: Annu. Rev. Genomics Hum. Genet.
  doi: 10.1146/annurev.genom.8.080706.092315
  contributor:
    fullname: Fortin
– volume: 102
  start-page: 329
  year: 2008
  ident: 10.1016/j.cell.2011.12.023_bib20
  article-title: Towards understanding the pathology of erythema nodosum leprosum
  publication-title: Trans. R. Soc. Trop. Med. Hyg.
  doi: 10.1016/j.trstmh.2008.01.004
  contributor:
    fullname: Kahawita
– ident: 10.1016/j.cell.2011.12.023_bib48
  doi: 10.1128/IAI.02061-05
– year: 2011
  ident: 10.1016/j.cell.2011.12.023_bib22
  contributor:
    fullname: Lawn
– start-page: CD000526
  year: 2002
  ident: 10.1016/j.cell.2011.12.023_bib25
  article-title: Interventions for treating tuberculous pericarditis
  publication-title: Cochrane Database Syst. Rev.
  contributor:
    fullname: Mayosi
– volume: 327
  start-page: 466
  year: 2010
  ident: 10.1016/j.cell.2011.12.023_bib43
  article-title: Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium
  publication-title: Science
  doi: 10.1126/science.1179663
  contributor:
    fullname: Volkman
SSID ssj0008555
Score 2.6064143
Snippet Susceptibility to tuberculosis is historically ascribed to an inadequate immune response that fails to control infecting mycobacteria. In zebrafish, we find...
SourceID pubmedcentral
proquest
crossref
pubmed
fao
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 434
SubjectTerms Animals
Danio rerio
Disease Models, Animal
eicosanoids
genotype
Humans
immune response
inflammation
Inflammation - immunology
Leukotriene A4 - genetics
Leukotriene A4 - immunology
Leukotriene B4 - genetics
Leukotriene B4 - immunology
Lipoxins - immunology
loci
meningitis
Mitochondria - metabolism
Mycobacterium
Mycobacterium Infections - drug therapy
Mycobacterium Infections - genetics
Mycobacterium Infections - immunology
Mycobacterium marinum
patients
polymorphism
Polymorphism, Genetic
Polymorphism, Single Nucleotide
Promoter Regions, Genetic
Signal Transduction
single nucleotide polymorphism
therapeutics
transcription (genetics)
Transcription, Genetic
tuberculosis
Tuberculosis, Meningeal - drug therapy
Tuberculosis, Meningeal - genetics
Tuberculosis, Meningeal - immunology
Tumor Necrosis Factor-alpha - metabolism
tumor necrosis factors
Zebrafish - embryology
Zebrafish - immunology
Title Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
URI https://dx.doi.org/10.1016/j.cell.2011.12.023
https://www.ncbi.nlm.nih.gov/pubmed/22304914
https://www.proquest.com/docview/920231372
https://search.proquest.com/docview/968167898
https://pubmed.ncbi.nlm.nih.gov/PMC3433720
Volume 148
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB71ISQuiPJqoFQ-cENR40eyybFdtewCbSXYohUXy3FsCFKdit0eyq9nbCerblV64JiHldgz_mZsz3wD8I5RQy2zLBU6y1IRDwlVllpNNeN1XY2Uz0Y-PSsmF-LjPJ9vwHjIhfFhlT32R0wPaN3fOehH8-CqbX2Ob8XKAi2izzahnhN023OZo2pvHx59-_R5BchlnsdCBhVOfmzQ587EMC-_Px6ZPP2uIOP_sk-bVnX3eaF3gylvWaeTp_CkdyvJYfzzHdgw7hk8ioUmb56DnnSLJflgXOe3XNNQdN62msxC9hUulslYOXKO8HHZ_jEEnUIydRaV5TIcwpMvMZIWn3Tk9EYjBgSOZ_zitA_mcosXMDs5no0naV9eIdW4yFimvLYK_SnP4I6rlqbAyd2g-8Br1mTcGlwoUauZMMxmlSrrUjeVyExjm6bKRSP4S9hynTO7QChDlFRlw1muhEVrV2Qav6F47r1JUyTwfhhTeRVJNOQQXfZLeglILwFJmUQJJJAPwy7XVEEiyj_YbhdlJNUPREd58ZV57rywY0OzBMggOInTx7dUznTXC1n58vGUj9gDrxQlRZNelQm8iqJedYKFU0oqEhitKcHqBU_evf7EtT8DiTcX3BcIev2fnX0Dj_GKhfhxvgdby9_X5i26R8t6v1f_fdiczo_w6mw8P__-F3gfD7A
link.rule.ids 230,314,780,784,885,3506,27569,27924,27925,45663,45874
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKEYIL4t3w9IEbiho_kk2OsKLsQrdIsJX2Zjl-lCDVqdjtofx6ZuxkxSLogWtsy7HH_mZsz3xDyGvOHPPc81yaoshleiTURe4NM1y0bTPRGI28OKlmp_LjqlztkekYC4NulQP2J0yPaD18ORxm8_Ci6zDGt-F1BRoRo00YcoLelGU9QQL9-erdFo7rskxpDBrY-lB9iJxJTl54O554PPFOkIt_aacbXvd_s0H_dKX8TTcd3SN3B6OSvk3_fZ_sufCA3EppJq8eEjPr1xv6wYUeL1zzmHLed4YuY-wVHJXpVAf6GcDjvPvpKJiEdB48LJXz-ARPvyQ_Wijp6eLKAAJEhmfocT64coX1I7I8er-czvIhuUJu4IixyUXrNVhTyN8OZxZbwda2YDyIlttCeAfHJOYNl477otF1WxvbyMJZb21TSivFY7If-uAOCGUcMFLXVvBSSw-6rioM9KFFibakqzLyZpxTdZEoNNToW_ZdoQQUSkAxrkACGSnHaVc7C0EBxl_b7gBkpPQZYKM6_cqROS_e17AiI3QUnILNgy11cP3lWjWYPJ6JCb-mSlUzUOhNnZEnSdTbQfD4RslkRiY7i2BbAam7d0tC9y1SeAspMD3Q0_8c7Ctye7ZcHKvj-cmnZ-QOlPDoSS6ek_3Nj0v3AgylTfsyboRfTqYOwg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Host+Genotype-Specific+Therapies+Can+Optimize+the+Inflammatory+Response+to+Mycobacterial+Infections&rft.jtitle=Cell&rft.au=Tobin%2C+David%C2%A0M&rft.au=Roca%2C+Francisco%C2%A0J&rft.au=Oh%2C+Sungwhan%C2%A0F&rft.au=McFarland%2C+Ross&rft.date=2012-02-03&rft.pub=Elsevier+Inc&rft.issn=0092-8674&rft.eissn=1097-4172&rft.volume=148&rft.issue=3&rft.spage=434&rft.epage=446&rft_id=info:doi/10.1016%2Fj.cell.2011.12.023&rft.externalDocID=US201600009310
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0092-8674&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0092-8674&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0092-8674&client=summon